Hospital Universitario Arnau de Vilanova

Lleida 25198

2 studies enrolling now · 7 studies all time

What they study most

Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Leukemia, Myeloid, Acute, Melanoma, Metastatic Breast Cancer, Metastatic Non Small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer, Recurrent Breast Cancer, Respiratory Syncytial Virus (RSV)

Studies at this site

• A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer — Recruiting now
• LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC — Recruiting now
• Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07) — Running, not enrolling
• A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma — Running, not enrolling
• A Study to Evaluate EDP 938 Regimens in Children With RSV — Completed
• A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia — Completed
• MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients — Stopped early